Supplement

– Cost Effective Supplements

Medium-chain triglycerides

Quick navigation


What are Medium-chain triglycerides's other names?

  • MCT oil
  • MCTs
  • Medium-chain fatty acids

What is Medium-chain triglycerides's recommended dosage?

    No intake information available.

What supplements interact with Medium-chain triglycerides?

No supplements that have a synergystic effect with this one.

What can Medium-chain triglycerides help with?

No studies that show the effects of this supplement on health conditions.

What is Medium-chain triglycerides used for?

  • Medium-chain triglycerides for Heart health

  • Medium-chain triglycerides for Weight loss

test
Slightly Positive


Replacement of LCT by MCT in the VLCD increased the rate of decrease of body fat and body weight and has a sparing effect on FFM. The intensity of hunger feelings was lower and paralleled the higher increase of ketone bodies. These effects gradually declined, indicating subsequent metabolic adaptation. Further studies are required to confirm the protein-sparing and appetite-suppressing effects of MCT supplementation during the first 2 weeks of VLCD treatment.


test
Slightly Positive


Results from this longest controlled MCT feeding study to date suggest that short-term feeding of MCT-enriched diets increases TEE, but this effect could be transient with continued feeding.


test
Slightly Positive


Results suggest that between day 7 and day 14 feeding of MCT vs. LCT at these levels, TEE is not affected and that increases seen in energy expenditure following MCT feeding may be of short duration. Thus, compensatory mechanisms may exist which blunt the effect of MCT on energy components over the longer term.


test
Slightly Positive


The capacity of MCT to increase endogenous oxidation of LCSFA suggests a role for MCT in body weight control over the long term.


test
Slightly Positive


These changes were associated with an involuntary reduction in energy intake in the MCT group (P < .05, repeated measures). A between-group comparison also shows reduced body weight, WC, and homeostasis model assessment of insulin resistance in the MCT group compared with the LCT group at the end of the study. Collectively, our results suggest a link between moderate consumption of MCT and improved risk factors in moderately overweight humans in a low-cost, free-living setting.


  • Medium-chain triglycerides for Insulin control


What are Medium-chain triglycerides's effects on the body?

  • Medium-chain triglycerides for the Digestive System

Replacement of LCT by MCT in the VLCD increased the rate of decrease of body fat and body weight and has a sparing effect on FFM. The intensity of hunger feelings was lower and paralleled the higher increase of ketone bodies. These effects gradually declined, indicating subsequent metabolic adaptation. Further studies are required to confirm the protein-sparing and appetite-suppressing effects of MCT supplementation during the first 2 weeks of VLCD treatment.


Results from this longest controlled MCT feeding study to date suggest that short-term feeding of MCT-enriched diets increases TEE, but this effect could be transient with continued feeding.


Results suggest that between day 7 and day 14 feeding of MCT vs. LCT at these levels, TEE is not affected and that increases seen in energy expenditure following MCT feeding may be of short duration. Thus, compensatory mechanisms may exist which blunt the effect of MCT on energy components over the longer term.


The capacity of MCT to increase endogenous oxidation of LCSFA suggests a role for MCT in body weight control over the long term.


These changes were associated with an involuntary reduction in energy intake in the MCT group (P < .05, repeated measures). A between-group comparison also shows reduced body weight, WC, and homeostasis model assessment of insulin resistance in the MCT group compared with the LCT group at the end of the study. Collectively, our results suggest a link between moderate consumption of MCT and improved risk factors in moderately overweight humans in a low-cost, free-living setting.


  • Medium-chain triglycerides for the Cardiovascular System

Scroll to top